A couple of days ago, I attended the FemHealth Integrates event in Manchester – which was excellent. I’ve always found it strange that over the last few years the clinical trials industry ...
I’ve been a big Formula 1 fan for many years. Indeed, probably foolishly, I considered myself too much of a purist to want to watch the Netflix series, Drive to Survive, when it first ...
I was chatting with a fellow patient recruitment specialist recently, and he used the phrase ‘any idiot can do patient recruitment’. I won’t reel off the list of names that came into my head ...
It’s been interesting to see the downplaying of the phrase DCT - Decentralized Trials – within the industry over the last few years. Starting with the COVID pandemic, for the next two or ...
I recently watched the first few episodes of the new reboot series of Bergerac – a UK detective series set on the island of Jersey. One of the scenes had the central character discussing a ...
It’s the fourth and final day of the 2025 SCOPE Summit in Orlando. From reading the many LinkedIn posts, and being in touch with people who are attending, I can tell it’s gone great. As ...
One of the highlights that stands out to me for today’s SCOPE Summit is the special book signing during the morning coffee break. I did my own signing in the same slot at last year’s event, ...
On the second day of this year’s SCOPE Summit, if I was in Orlando I’m pretty sure I would not have been starting off with the 5k Rise and Shine fun run at 6.30 am. Especially after last ...
Unlike many of you, I’m unfortunately not able to attend the SCOPE Summit over the next few days, and am here in a reasonably sunny Manchester rather than there in an almost certainly more ...
Respect for the disease or condition that the potential treatment is designed to work on is another essential factor. When I talk about respect in this regard, I mean being aware of the ...